114 results
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GLP-1 Agonists ... Semaglutide) Weekly Trulicity ... -1 Agonists are ... However, GLP-1's ... #GLP1 #Agonists
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... the pancreas (GLP ... • Dulaglutide (Trulicity ... EricsMedicalLectures/featured #GLP1 ... #Receptor #Agonists
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
- PPAR gamma agonist ... INCRETIN AGENTS • GLP ... -1 agonists ... - Dulaglutide (Trulicity ... - Prevents GLP
GLP-1 Medications: Ozempic vs. Trulicib (semaglutide vs. dulaglutide) 

From my experience, Ozempic and Trulicity are the
GLP-1 Medications ... commonly used GLP1 ... Which GLP1 do you ... Both of these GLP1 ... reminder, we use GLP1
Algorithm for prescribing SGLT2 inhibitors and GLP1 agonists

This algorithm prioritizes the prescription of SGLT2i and GLP-1
inhibitors and GLP1 ... agonists This ... of SGLT2i and GLP ... -1 Receptor Agonists ... #SGLT2 #GLP1 #prescribing
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
) - First Oral GLP ... -1 Agonist Dosing ... agonist! ... agonists. ... GLP1 agonists are
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Meglitinides • GLP ... -1 Receptor Agonists
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Sulfonylureas GLP ... -1 receptor agonists
Classification of Adrenergic Receptor Agonists (sympathomymetics)

#Adrenergic #Receptor #Agonists #sympathomymetics #Classification #Pharmacology
Adrenergic Receptor Agonists ... Adrenergic #Receptor #Agonists
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
mu-opioid receptor agonist ... displacing full agonists ... As a partial agonist ... However, full agonists ... As a partial agonist